Amgen, Inc. (AMGN) Misses Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $417.84 --0%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Amgen, Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.87, $0.07 worse than the analyst estimate of $1.94. Revenue for the quarter came in at $4.52 billion versus the consensus estimate of $4.76 billion.
For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
- Amgen (AMGN) PT Raised to $380 at Barclays
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
